European Pharmaceutical Review

JANUARY 18, 2024

GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. million in sales by 2032.

Marketing 98

Marketing Sales Pharmacology Pharma 98

Legacy MEDSearch

JUNE 15, 2023

The Cala kIQ System with TAPS therapy offers a non-invasive, non-pharmacologic solution with minimal side effects. Founded in 2014, the company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

Patients 98

Patients Recruitment Pharmacology Management 98

European Pharmaceutical Review

JULY 4, 2024

Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets. She obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. Available from: [link] Apply for a traditional herbal registration (THR) [Internet].

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

European Pharmaceutical Review

JULY 13, 2023

This could lead to significant research waste. This will lead to a higher proportion of these medicines becoming licensed, benefitting a larger number of patients. He leads the pre-clinical and clinical medical cannabis research programmes in Europe and is responsible for the cannabis clinic rollout across the continent.

Medical 98

Medical Food and Drug Administration Pharmacology Medicine 98